Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.
Epstein-Barr virus (EBV) is a ubiquitous DNA virus that normally infects silently, establishing lifelong latency. Substantial empirical observations support the view that immunodeficiency is permissive in EBV-induced lymphoproliferative diseases (LPD). Primary immune deficient patients such as those...
Main Authors: | Purtilo, D T, Okano, M, Grierson, H L |
---|---|
Format: | Online |
Language: | English |
Published: |
1990
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568028/ |
Similar Items
-
Epstein–Barr Virus, the Immune System, and Associated Diseases
by: Chen, Mei-Ru
Published: (2011) -
The role of Epstein–Barr virus in epithelial malignancies
by: Tsao, Sai-Wah, et al.
Published: (2015) -
The Epstein-Barr Virus
by: Payne, L. N.
Published: (1980) -
Epstein–Barr virus vaccines
by: Cohen, Jeffrey I
Published: (2015) -
Epstein–barr virus vaccines
by: Cohen, Jeffrey I
Published: (2015)